Zdrowie i gospodarka · 14/06/2000
FDA Announces Draft Guidance for Parathyroid Hormone in Osteoporosis Treatment
The FDA is releasing a draft guidance to help the development of parathyroid hormone as a treatment for osteoporosis, following concerns raised by preclinical studies on rats and mice
Source: Federal Register — Food and Drug AdministrationOpen original release →